Erythromycin Stearate from Japan
Erythromycin stearate is the stearate salt derivative of the macrolide antibiotic erythromycin, used primarily to treat bacterial infections such as respiratory tract infections and skin infections. It falls under HTS 2941.50.00.00 as a salt of erythromycin, explicitly covered by the heading for antibiotics in this category. This chemically defined organic compound is supplied as a pharmaceutical intermediate or active ingredient.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Verify purity certificates and batch analysis to meet FDA import requirements; ensure proper cold chain documentation if temperature-sensitive
• Avoid misclassification as finished dosage forms